-
1
-
-
0017232852
-
Familial hepatic venoocclusive disease with probable immune deficiency
-
COI: 1:STN:280:DyaE287it1Wnuw%3D%3D, PID: 1249685
-
Mellis C, Bale PM. Familial hepatic venoocclusive disease with probable immune deficiency. J Pediatr. 1976;88:236–42.
-
(1976)
J Pediatr
, vol.88
, pp. 236-242
-
-
Mellis, C.1
Bale, P.M.2
-
2
-
-
33745258176
-
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease
-
COI: 1:CAS:528:DC%2BD28XltVOhtbw%3D, PID: 16648851
-
Roscioli T, et al. Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet. 2006;38:620–2.
-
(2006)
Nat Genet
, vol.38
, pp. 620-622
-
-
Roscioli, T.1
-
3
-
-
85029617163
-
Hepatic veno-occlusive disease with immunodeficiency
-
GeneReviews(R), Seattle
-
Roscioli, T., Ziegler, J.B., Buckley, M. & Wong, M. Hepatic veno-occlusive disease with immunodeficiency. In: Pagon RA, et al., editors. GeneReviews(R). Seattle; 1993.
-
Pagon RA, et al., editors
, pp. 1993
-
-
Roscioli, T.1
Ziegler, J.B.2
Buckley, M.3
Wong, M.4
-
4
-
-
84865684727
-
Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome
-
COI: 1:CAS:528:DC%2BC38XntlyktLc%3D, PID: 22621957
-
Cliffe ST, et al. Clinical, molecular, and cellular immunologic findings in patients with SP110-associated veno-occlusive disease with immunodeficiency syndrome. J Allergy Clin Immunol. 2012;130:735–742.e6.
-
(2012)
J Allergy Clin Immunol
, vol.130
, pp. 735-742.e6
-
-
Cliffe, S.T.1
-
5
-
-
84876448639
-
The role of hematopoietic stem cell transplantation in SP110 associated veno-occlusive disease with immunodeficiency syndrome
-
PID: 23448538
-
Ganaiem H, et al. The role of hematopoietic stem cell transplantation in SP110 associated veno-occlusive disease with immunodeficiency syndrome. Pediatr Allergy Immunol. 2013;24:250–6.
-
(2013)
Pediatr Allergy Immunol
, vol.24
, pp. 250-256
-
-
Ganaiem, H.1
-
6
-
-
84866010021
-
Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110
-
COI: 1:CAS:528:DC%2BC38XhsFKnsLrL, PID: 22982295
-
Wang T, Ong P, Roscioli T, Cliffe ST, Church JA. Hepatic veno-occlusive disease with immunodeficiency (VODI): first reported case in the U.S. and identification of a unique mutation in Sp110. Clin Immunol. 2012;145:102–7.
-
(2012)
Clin Immunol
, vol.145
, pp. 102-107
-
-
Wang, T.1
Ong, P.2
Roscioli, T.3
Cliffe, S.T.4
Church, J.A.5
-
7
-
-
84865393696
-
SP110 gene polymorphisms and tuberculosis susceptibility: a systematic review and meta-analysis based on 10 624 subjects
-
COI: 1:CAS:528:DC%2BC38Xht1KktLbM, PID: 22691368
-
Lei X, Zhu H, Zha L, Wang Y. SP110 gene polymorphisms and tuberculosis susceptibility: a systematic review and meta-analysis based on 10 624 subjects. Infect Genet Evol. 2012;12:1473–80.
-
(2012)
Infect Genet Evol
, vol.12
, pp. 1473-1480
-
-
Lei, X.1
Zhu, H.2
Zha, L.3
Wang, Y.4
-
8
-
-
84973096924
-
Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy
-
COI: 1:CAS:528:DC%2BC28XnvFeisbg%3D, PID: 27185954
-
Ivansson EL, et al. Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy. Proc Natl Acad Sci U S A. 2016;113:E3091–100.
-
(2016)
Proc Natl Acad Sci U S A
, vol.113
, pp. E3091-E3100
-
-
Ivansson, E.L.1
-
9
-
-
0032973688
-
Structural and functional heterogeneity of nuclear bodies
-
COI: 1:CAS:528:DyaK1MXjt1yis78%3D, PID: 10330182
-
Bloch DB, et al. Structural and functional heterogeneity of nuclear bodies. Mol Cell Biol. 1999;19:4423–30.
-
(1999)
Mol Cell Biol
, vol.19
, pp. 4423-4430
-
-
Bloch, D.B.1
-
10
-
-
0036839055
-
Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1
-
COI: 1:CAS:528:DC%2BD38XnvFKjtr4%3D, PID: 12368356
-
Madani N, et al. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1. J Virol. 2002;76:11133–8.
-
(2002)
J Virol
, vol.76
, pp. 11133-11138
-
-
Madani, N.1
-
11
-
-
84977529301
-
Insert, remove or replace: a highly advanced genome editing system using CRISPR/Cas9
-
COI: 1:CAS:528:DC%2BC28XhtVKnsb3K, PID: 27350235
-
Ceasar SA, Rajan V, Prykhozhij SV, Berman JN, Ignacimuthu S. Insert, remove or replace: a highly advanced genome editing system using CRISPR/Cas9. Biochim Biophys Acta. 2016;1863:2333–44.
-
(2016)
Biochim Biophys Acta
, vol.1863
, pp. 2333-2344
-
-
Ceasar, S.A.1
Rajan, V.2
Prykhozhij, S.V.3
Berman, J.N.4
Ignacimuthu, S.5
-
12
-
-
47949089923
-
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus
-
COI: 1:CAS:528:DC%2BD1cXhtVSktbrF, PID: 18063674
-
Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis. 2008;67:1069–75.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 1069-1075
-
-
Nikpour, M.1
Dempsey, A.A.2
Urowitz, M.B.3
Gladman, D.D.4
Barnes, D.A.5
-
13
-
-
0034598746
-
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
-
COI: 1:CAS:528:DC%2BD3cXht1Shtrg%3D, PID: 10676951
-
Alizadeh AA, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.
-
(2000)
Nature
, vol.403
, pp. 503-511
-
-
Alizadeh, A.A.1
-
14
-
-
0037142053
-
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
-
PID: 12075054
-
Rosenwald A, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–47.
-
(2002)
N Engl J Med
, vol.346
, pp. 1937-1947
-
-
Rosenwald, A.1
|